This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Marjolein van Egmond
Professor of Oncology and Inflammation at Amsterdam University Medical Center

Profile

The research group of Dr. van Egmond studies antibody activation of innate myeloid immune cells, i.e. macrophages and neutrophils, with emphasis on understanding the role of immunoglobulin A (IgA) in physiology and pathology.  Her research focuses specifically on (1) the contribution of abnormal antibody responses to chronic inflammation and autoimmunity and (2) monoclonal antibody therapy of cancer. Dr. van Egmond’s research is highly translational and she has a cross appointment with the Department of Surgery and the Department of Molecular Cell Biology and Immunology, to facilitate the rapid progression of pre-clinical findings into clinical applications.

Agenda Sessions

  • The Truth About IgA?

    2:45pm